Head-to-head · WeighScore
Clume Health vs RX Bella
By GLP-1 ScorecardUpdated
Score comparison
RX Bella has the higher recorded score — 67.8/100 to 63.7/100.
RX Bella grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four routes priced from a floor on the homepage, a hero quoting the cheapest of the four, and treatment pages that carry no price at all.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Clume Health | RX Bella |
|---|---|---|
| WeighScore | 63.7/100 | 67.8/100 |
| Grade | C | C |
| Site position | #279 | #175 |
| Semaglutide | $259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan) | From $249/mo (a floor, not a rate) |
| Tirzepatide | $259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan) | From $299/mo (a floor, not a rate) |
| Coverage | All 50 states plus Washington, D.C. | Nationwide telehealth, claimed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #279 · C
Strengths
- One Signature price covers semaglutide or tirzepatide, injectable or oral, so switching molecule or route does not change the bill
- A separate microdose and maintenance program is priced on its own at $219 a month rather than sold as a discount on the main line
- Names four dispensing pharmacies with street addresses and phone numbers, which is more than most of the field publishes
- States service in all 50 states plus Washington, D.C. without contradicting itself elsewhere
- A full refund is available if the subscription is canceled within the first 72 hours and before the medication ships
What to consider
- Neither homepage hero price matches anything sold: $199 a month is advertised against real floors of $259 and $219, and $159 against a figure of $216 that itself needs a 12-week plan
- Both hero prices carry an asterisk that resolves to no footnote anywhere on the page
- The cheaper monthly figures are commitments — $186 needs 52 weeks and $200 needs 12 — printed on the same card as the month-to-month rate
- The refund policy promises a 24/7 patient support line and no phone number appears anywhere on the site; support is email only
- Whether the medication is compounded, and under 503A or 503B, is never stated
- No clinician is named. The Terms name only “the OpenLoop Medical Practices”, with no individual, no NPI and no medical group entity
Site position #175 · C
Strengths
- All four programs — microdose, oral, semaglutide injection, tirzepatide injection — carry a figure on the homepage before any intake
- Nothing in the catalog is struck through: no invented "was" price and no expiring offer
- "$0 if you're not approved" is stated plainly and repeatedly
- The online provider visit, prescription, delivery and ongoing check-ins are stated as included
What to consider
- The hero's "from $199/mo" is the microdose; the tirzepatide program is $299
- Every figure is a floor, no dose ladder is published, and the eight-screen intake reaches an email gate without showing a price
- Its own treatment pages carry no dollar figure and read "AVAILABLE BY CONSULTATION"
- No lab or monitoring requirement is published
- The compounding pharmacies are never named and the footer names no company
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.